Correlation Between Santen Pharmaceutical and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Santen Pharmaceutical and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santen Pharmaceutical and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Santen Pharmaceutical Co and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Santen Pharmaceutical and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santen Pharmaceutical with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santen Pharmaceutical and AstraZeneca PLC.

Diversification Opportunities for Santen Pharmaceutical and AstraZeneca PLC

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Santen and AstraZeneca is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Santen Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santen Pharmaceutical Co are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Santen Pharmaceutical i.e., Santen Pharmaceutical and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Santen Pharmaceutical and AstraZeneca PLC

Assuming the 90 days horizon Santen Pharmaceutical Co is expected to under-perform the AstraZeneca PLC. In addition to that, Santen Pharmaceutical is 1.07 times more volatile than AstraZeneca PLC ADR. It trades about -0.31 of its total potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about -0.28 per unit of volatility. If you would invest  7,601  in AstraZeneca PLC ADR on August 27, 2024 and sell it today you would lose (961.00) from holding AstraZeneca PLC ADR or give up 12.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Santen Pharmaceutical Co  vs.  AstraZeneca PLC ADR

 Performance 
       Timeline  
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
AstraZeneca PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Santen Pharmaceutical and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Santen Pharmaceutical and AstraZeneca PLC

The main advantage of trading using opposite Santen Pharmaceutical and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santen Pharmaceutical position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind Santen Pharmaceutical Co and AstraZeneca PLC ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum